Endoscopic diagnosis of gastrointestinal graft-versus-host disease

Table 1 Characteristics of patients with GVHD

Case No./Sex/Age	Diagnosis	Conditioning regimens	Donor HLA match	GVHD prophylaxis	Stage grading
1/F/29	AML-M2	BU/CY	HLA 2-locus mismatched unrelated donor	CSA, ATG, MMFMTX	aGVHD grade IV
2/M/47	CML-CR	Fludarabine, Bu, ATG	HLA-identical sibling donor	CSA, MTX	cGVHD Limited
3/M/39	CML -CR	BU/CY	HLA-identical sibling donor	CSA, MTX	cGVHD/Limited
4/M/23	CML-CR	BU/CY	HLA-identical sibling donor	CSA, MTX	aGVHD grade IV
5/M/63	CML-CR	Fludarabine, Bu, ATG	HLA-identical sibling donor	CSA, MTX	aGVHD grade IV
6/F/35	ALL-CR	Me-CCNU, TBI, Ara-C, CY	HLA 2-locus mismatched related donor	CSA, MTX, MMF, ATG	aGVHD grade IV
7/M/42	ALL-CR	BU/CY, Me-CCNU, Ara-C	HLA 2-locus mismatched related donor	CSA, MTX, MMF, ATG	aGVHD grade III
8/F/23	ALL-CR	Me-CCNU, TBI, Ara-C, CY	HLA 2-locus mismatched related donor	CSA, MTX, MMF, ATG Anti-CD25	aGVHD grade III

HLA: Human leucocyte antigen.

Table 2 Gastrointestinal symptoms of patients with GI GVHD

Case No./Sex/Age	Nausea	Vomiting	Anorexia	Abdominal pain	Diarrhea	Gastrointestinal bleeding
1/F/29	+	+	+	+	+	+
2/M/47	+	+	+	-	-	-
3/M/39	-	-	-	-	+	+
4/M/23	+	+	-	+	+	+
5/M/63	-	-	-	+	+	-
6/F/35	+	-	-	+	+	+
7/M/42	+	-	+	+	+	-
8/F/23	+	+	-	-	+	-